In TIMER, after adjustments for tumor purity, the ENO1 expression level was significantly correlated with 14 out of 57 immune cell markers in CESC, 30 out of 57 immune cell markers in KICH, and 24 out of 57 immune cell markers in LUAD. The gene discussed is ENO1; the disease is neoplasm.